CD8A and infection: In an experimental human RSV infection model, the abundance of RSV-specific, pulmonary CD8+ TRM before infection was associated with reduced symptoms and viral load, implying that CD8+ TRM can confer protection against severe respiratory viral disease when humoral immunity is overcome (8).